AMNEAL PHARMACEUTICALS INC (AMRX)
US03168L1052 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 91.54M | 25.98M | 247.79M | 341.40M | 151.20M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 645.66M | 796.91M | 727.74M | 674.20M | 635.90M | |||
| Inventories | 581.38M | 530.74M | 489.39M | 490.60M | 381.10M | |||
| Other Current Assets | 59.28M | 58.20M | 55.19M | 45.30M | 42.00M | |||
| Total Current Assets | 1.38B | 1.41B | 1.52B | 1.55B | 1.21B | |||
| Non-Current Assets | ||||||||
| PPE Net | 550.14M | 589.36M | 639.00M | 605.20M | 620.20M | |||
| Goodwill | 598.63M | 598.85M | 593.02M | 522.80M | 419.50M | |||
| Intangibles | 890.42M | 1.10B | 1.17B | 1.30B | 1.38B | |||
| Other Non-Current Assets | 55.52M | 103.22M | 20.61M | 21.90M | 33.30M | |||
| Total Non-Current Assets | 2.09B | 2.39B | 2.42B | 2.45B | 2.46B | |||
| TOTAL ASSETS | 3.47B | 3.80B | 3.94B | 4.01B | 3.67B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 179.00M | 60.00M | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 36.59M | 33.45M | 33.72M | 48.40M | 23.50M | |||
| Accrued Expenses | 403.12M | 383.05M | 404.06M | 464.30M | 410.20M | |||
| Accounts Payable | 143.57M | 165.98M | 189.08M | 151.10M | 102.00M | |||
| Other Current Liabilities | 84.31M | 110.32M | 50.38M | 13.10M | 14.70M | |||
| Total Current Liabilities | 846.60M | 752.80M | 677.24M | 676.90M | 550.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.49B | 2.69B | 2.78B | 2.83B | 2.67B | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Liabilities | 78.65M | 145.16M | 100.20M | 138.20M | 94.20M | |||
| Total Non-Current Liabilities | 2.61B | 2.75B | 2.90B | 3.03B | 2.88B | |||
| TOTAL LIABILITIES | 3.45B | 3.50B | 3.58B | 3.70B | 3.43B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -490.18M | -406.18M | -276.20M | -286.80M | -377.90M | |||
| Additional Paid In Capital | 539.24M | 691.63M | 658.35M | 628.40M | 607.00M | |||
| Minority Interest | 6.25M | 35.31M | 13.99M | 76.00M | 356.50M | |||
| Common Shares | 3.07M | 3.04M | 3.01M | 3.00M | 3.00M | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | -32.35M | 9.94M | -24.83M | -41.30M | -100.00K | |||
| Shares Outstanding | 458.68M | 303.61M | 301.53M | 299.80M | 299.20M | |||
| Tangible Book Value per Share | -3.20 | -4.60 | -4.64 | -5.08 | -5.25 | |||
| Total Shareholders' Equity | 19.78M | 298.42M | 360.34M | 303.30M | 232.00M | |||
| TOTAL LIABILITIES AND EQUITY | 3.47B | 3.80B | 3.94B | 4.01B | 3.67B | |||
| Statistics | ||||||||
| Debt/Equity | 134.73 | 9.22 | 7.71 | 9.34 | 11.53 | |||
| Current Ratio | 1.63 | 1.88 | 2.24 | 2.29 | 2.20 | |||
| Return On Assets (ROA) | -2.42% | -3.42% | 0.27% | 2.27% | -9.87% | |||
| Return On Equity (ROE) | -424.61% | -43.56% | 2.95% | 30.04% | -155.99% | |||
| Return On Invested Capital (ROIC) | 7.74% | 5.07% | 5.24% | 3.46% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 8.00% | 5.11% | 5.67% | 3.85% | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 17.73% | 11.36% | 13.63% | 9.92% | N/A | |||
All data in USD